PRATESI, NICOLA
PRATESI, NICOLA
FISIOPATOLOGIA CLINICA (attivo dal 01/08/1980 al 31/12/2012)
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.
2011 Nicola Pratesi; Monica Mangoni; Irene Mancini; Fabiola Paiar; Lisa Simi; Lorenzo Livi; Sara Cassani; Michela Buglione; Salvatore Grisanti; Camillo Almici; Caterina Polli; Calogero Saieva; Stefano Maria Magrini; Giampaolo Biti; Mario Pazzagli; Claudio Orlando
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR.
2011 Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C
From clinical trials to clinical practice: predictors ofresponse to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy
2011 Mazzoni F; Rotella V; Pratesi N; Boni L; Simi L; Orlando C; Comin CE; Maddau C; Di Costanzo F
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers
2011 Vinci, Serena; Gelmini, Stefania; Pratesi, Nicola; Conti, Simona; Malentacchi, Francesca; Simi, Lisa; Pazzagli, Mario; Orlando, Claudio
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers.
2011 Vinci S; Gelmini S; Pratesi N; Conti S; Malentacchi F; Simi L; Pazzagli M; Orlando C.
La Farmacogenetica nel trattamento radioterapico del carcinoma testa-collo
2013 Pratesi, Nicola
The clinical role of PIK3CA mutations in colorectal cancer
2008 Pratesi N, Simi L, Sestini R, Nobili S, Vignoli M, Landini I, Cianchi F, Valanzano R, Genuardi M, Mini E, Orlando C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. | 2011 | Nicola Pratesi; Monica Mangoni; Irene Mancini; Fabiola Paiar; Lisa Simi; Lorenzo Livi; Sara Cassani; Michela Buglione; Salvatore Grisanti; Camillo Almici; Caterina Polli; Calogero Saieva; Stefano Maria Magrini; Giampaolo Biti; Mario Pazzagli; Claudio Orlando | |
| BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. | 2011 | Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C | |
| From clinical trials to clinical practice: predictors ofresponse to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy | 2011 | Mazzoni F; Rotella V; Pratesi N; Boni L; Simi L; Orlando C; Comin CE; Maddau C; Di Costanzo F | |
| Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers | 2011 | Vinci, Serena; Gelmini, Stefania; Pratesi, Nicola; Conti, Simona; Malentacchi, Francesca; Simi, Lisa; Pazzagli, Mario; Orlando, Claudio | |
| Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. | 2011 | Vinci S; Gelmini S; Pratesi N; Conti S; Malentacchi F; Simi L; Pazzagli M; Orlando C. | |
| La Farmacogenetica nel trattamento radioterapico del carcinoma testa-collo | 2013 | Pratesi, Nicola | |
| The clinical role of PIK3CA mutations in colorectal cancer | 2008 | Pratesi N, Simi L, Sestini R, Nobili S, Vignoli M, Landini I, Cianchi F, Valanzano R, Genuardi M, Mini E, Orlando C |